Access Bio, Inc. (KOSDAQ:950130)
 3,905.00
 -20.00 (-0.51%)
  Oct 31, 2025, 3:30 PM KST
Access Bio Market Cap
Access Bio has a market cap or net worth of 138.06 billion as of October 31, 2025. Its market cap has decreased by -52.96% in one year.
Market Cap 
 138.06B
Enterprise Value 
 -210.25B
Revenue 
 74.42B
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
3,905.00
Market Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 138.06B, a decrease of -48.70%. That is a compound annual growth rate of -5.23%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 138.06B | -24.37% | 
| Dec 30, 2024 | 182.55B | -39.72% | 
| Dec 28, 2023 | 302.84B | -26.91% | 
| Dec 29, 2022 | 414.36B | -27.26% | 
| Dec 30, 2021 | 569.63B | -27.38% | 
| Dec 30, 2020 | 784.36B | 1,061.10% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 86.90T | 
| Celltrion | 38.90T | 
| ALTEOGEN | 24.95T | 
| SK Biopharmaceuticals | 8.97T | 
| Yuhan | 8.77T | 
| HLB Co., Ltd. | 6.30T | 
| Peptron | 6.18T | 
| PharmaResearch | 5.36T |